Cardlytics: Amit Gupta proposes $28.1K share sale
The notice also lists four sales by Amit Gupta during the preceding three months.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cardlytics, Inc. (CDLX) is named as issuer in Amit Gupta's notice covering a proposed sale of 10,351 common shares, with an aggregate market value of $28,051.21 and an approximate sale date of October 1, 2026. Gupta is identified as an officer and director. The shares are listed as restricted-stock vesting compensation, and the sale includes an amount necessary to cover a tax obligation resulting from settlement of a vested equity award distribution. Fidelity Brokerage Services LLC is listed as broker.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Vesting financial
attorney-in-fact regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.